Devyser completes private placement of SEK 130 million to Swedbank Robur and AP4
Stockholm, February 2, 2021 – Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announced the completion of a private placement of 7,465 shares, corresponding to SEK 130 million before issuance costs, to Swedbank Robur and the Fourth Swedish National Pension Fund (AP4). The purpose of the issue is primarily to finance the company’s global marketing and sales expansion.As part of the private placement, Swedbank Robur and AP4 subscribed for shares valued at SEK 80 million and SEK 50 million, respectively. Following the issue, they will hold 12 percent and 8 percent,